3 results for "Obstetrics and Gynecology"

Premenopausal Uterine Fibroids and the effects of Elagolix with Estradiol/Norethindrone Acetate

This study assesses the safety and efficacy of Elagolix 300 mg BID in combination with E2/NETA (estradiol 1.0 mg/norethindrone acetate 0.5 mg QD) compared to placebo in reducing heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Premenopausal Women with Uterine Fibroids and the effects of Elagolix

This study evaluates the long-term efficacy and safety of Elagolix administered alone and in combination with add-back therapy (estradiol/norethindrone acetate or E2/NETA) to reduce heavy menstrual bleeding (HMB) associated with uterine fibroids.

Endometriosis-Associated Pain and the effects of Elagolix with Estradiol/Norethindron Acetate

This study evaluates the safety and efficacy of Elagolix in combination with concomitant hormonal add-back therapy (E2/NETA) in the management of endometriosis-associated pain (EAP) in premenopausal women.